Close

Merck (MRK) Announces Significant Data from KEYTRUDA in Adv. Bladder Cancer

Go back to Merck (MRK) Announces Significant Data from KEYTRUDA in Adv. Bladder Cancer
Merck & Co. (NYSE: MRK) Delayed: 132.54 +5.54 (4.36%)
Previous Close $127.00    52 Week High $65.46 
Open $129.69    52 Week Low $47.97 
Day High $132.80    P/E 90.16 
Day Low $129.45    EPS $1.47 
Volume 1,722,732